Optimizing Screen Failures in Clinical Trials
Screen failures in clinical research are a necessary, unpredictable, and disruptive part of the...
Featured contributor to the SCRS initiative reducing redundant site training by 25%+
The Patient Perspective in Oncology Research Participation
Screen failures in clinical research are a necessary, unpredictable, and disruptive part of the...
Table of Contents 📄 The Forecasting Problem No One Wants to Talk About 📄 What Data-Driven...
Choosing the right technology to engage clinical trial sites is crucial for study success. Two...
Don’t believe the hype. Most patient dropouts CANNOT be avoided. In my 23 years of clinical...
Over the past year, ProofPilot truly leveled up—we generated amazing customer experiences, joined...
ProofPilot’s acquisition of Lokavant is a move that will have a significant, high-value impact on...
Clinical research is complex, and rightfully so. What we do is often uncharted and difficult....
In a recent interview with The Clinical Trial Vanguard, our Chief Strategy Officer, Joseph Kim...
If you missed DPharm 2024, you also missed watching a live matchmaking event with Nichole Gallatti,...
There is nothing more important in clinical research execution than ensuring sites and patients...
Trial feasibility sometimes feels like a progressive game of bait and switch. In other words, early...
We know clinical trials are vital for developing new medicines, medical devices, and diagnostic...